All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company Call
|
|
|
|
|
|
|
|
ASGN / ASGN Incorporated
|
|
|
|
|
|
|
|
HCA / HCA Healthcare, Inc.
|
|
|
|
|
|
|
|
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
EBS / Emergent BioSolutions Inc.
|
|
|
|
|
|
|
|
AMN / AMN Healthcare Services, Inc.
|
|
|
|
|
|
|
|
HRC / Hill-Rom Holdings Inc
|
|
|
|
|
|
|
|
SIOX / Sio Gene Therapies Inc.
|
|
|
|
|
|
|
|
MEIP / MEI Pharma, Inc.
|
|
|
|
|
|
|
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
VRAY / ViewRay Inc.
|
|
|
|
|
|
|
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
/ PHILLIPS EDISON & CO INC
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
ETON / Eton Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
VAPO / Vapotherm, Inc.
|
|
|
|
|
|
|
|
CASI / CASI Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CAH / Cardinal Health, Inc.
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
VREX / Varex Imaging Corporation
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
ITGR / Integer Holdings Corporation
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
OFIX / Orthofix Medical Inc.
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
ZSAN / Zosano Pharma Corp
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
MOH / Molina Healthcare, Inc.
|
|
|
|
|
|
|
|
WBA / Walgreens Boots Alliance, Inc.
|
|
|
|
|
|
|
|
OSMT / Osmotica Pharmaceuticals Plc
|
|
|
|
|
|
|
|
BDX / Becton, Dickinson and Company
|
|
|
|
|
|
|
|
RDUS / Radius Recycling, Inc.
|
|
|
|
|
|
|
|
HLF / Herbalife Ltd.
|
|
|
|
|
|
|
|
FREQ / Frequency Therapeutics Inc Put
|
|
|
|
|
|
|
|
ONCT / Oncternal Therapeutics, Inc.
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
CVM / CEL-SCI Corporation Put
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
CCRN / Cross Country Healthcare, Inc.
|
|
|
|
|
|
|
|
SYNH / Syneos Health Inc - Class A
|
|
|
|
|
|
|
|
US92731L1145 / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
HROW / Harrow, Inc.
|
|
|
|
|
|
|
|
OTRK / Ontrak, Inc.
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CRDF / Cardiff Oncology, Inc.
|
|
|
|
|
|
|
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMAB / I-Mab - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ANIK / Anika Therapeutics, Inc.
|
|
|
|
|
|
|
|
SPRB / Spruce Biosciences, Inc.
|
|
|
|
|
|
|
|
GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
|
|
|
|
|
|
|
|
MED / Medifast, Inc. Put
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SLRX / Salarius Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
UHS / Universal Health Services, Inc.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GLD / SPDR Gold Trust
|
|
|
|
|
|
|
|
SOLY / Soliton Inc
|
|
|
|
|
|
|
|
DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
CMAX / CareMax, Inc.
|
|
|
|
|
|
|
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MEOBF / Mesoblast Limited Put
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
AYLA / Ayala Pharmaceuticals Inc
|
|
|
|
|
|
|
|
RUBY / Rubius Therapeutics, Inc.
|
|
|
|
|
|
|
|
ABC / Amerisource Bergen Corp.
|
|
|
|
|
|
|
|
NTUS / Natus Medical Inc
|
|
|
|
|
|
|
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
BNGO / Bionano Genomics, Inc.
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
NBSE / NeuBase Therapeutics, Inc.
|
|
|
|
|
|
|
|
MCK / McKesson Corporation
|
|
|
|
|
|
|
|
EUCRU / Eucrates Biomedical Acquisition Corp
|
|
|
|
|
|
|
|
SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
GSK / GSK plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
MBRX / Moleculin Biotech, Inc.
|
|
|
|
|
|
|
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ICLR / ICON Public Limited Company
|
|
|
|
|
|
|
|
CLRB / Cellectar Biosciences, Inc.
|
|
|
|
|
|
|
|